Details - University of Chicago Medicine Faculty Profiles

Caner Saygin

Section of Hematology / Oncology

Assistant Professor of Medicine

Academic Interests

Dr. Saygin is a physician scientist with a translational research laboratory focused on understanding leukemia biology and genetics, as well as developing novel therapies for these diseases. He studies the mechanisms by which leukemias arise from precursor conditions such as clonal hematopoiesis. This is done by working with primary cells from patient samples, and modeling these entities in research laboratory. Dr. Saygin was involved in preclinical development of several experimental therapeutics for treatment of ALL and AML. He also runs a Clonal Hematopoiesis Clinic, where he sees patients with high-risk preleukemic conditions and focuses on interventions that may halt the progression towards leukemia. Dr. Saygin is focused on the development and conduct of novel therapeutic trials for these diseases, both at the institutional and national level.

Clinical Interests

Clonal hematopoiesis of indeterminate potential (CHIP), clonal cytopenia of undetermined significance (CCUS), acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), myelodysplastic syndromes (MDS), chronic lymphocytic leukemia (CLL), chronic myeloid leukemia (CML), hairy cell leukemia (HCL), cytopenias

Publications

For a complete list of publications click here:

Training

MD, 2014, Istanbul University Cerrahpasa Medical Faculty
Postdoctoral Resarch Fellow, 2017, Cleveland Clinic, Cellular and Molecular Medicine
Residency, 2020, The Ohio State University, General Internal Medicine
Fellowship, 2023, The University of Chicago Medical Center, Hematology-Oncology